Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-novel coronavirus drug and application thereof

A new type of coronavirus technology, applied in antiviral agents, drug combinations, antipyretics, etc., can solve the problem that there is no specific treatment for the disease

Pending Publication Date: 2020-10-23
THE THIRD PEOPLES HOSPITAL OF SHENZHEN
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no specific treatment for the disease caused by the new coronavirus, and the production of antibodies and vaccines also needs a large number of clinical trials to verify

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-novel coronavirus drug and application thereof
  • Anti-novel coronavirus drug and application thereof
  • Anti-novel coronavirus drug and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] This application selects VERO cells (African green monkey kidney cells) susceptible to the new coronavirus (2019-nCoV) as the research object (Vero is currently the main cell line used in in vitro experiments for drug screening of new coronaviruses). Culture conditions: DMEM containing 10% serum, placed at 37°C, containing 5% CO 2 cultivated in an incubator.

[0021] The new coronavirus used in the experiment was isolated from throat swabs of patients in Shenzhen Third People's Hospital in February 2020, and the sequence information has been uploaded to the GISAID database (BetaCoV / Shenzhen / SZTH-003 / 2020strainvirusGISAID access number: EPI_ISL_406594).

[0022] The resveratrol used in the experiment was purchased from SIGMA Company, product number (R5010, purity ≥ 99%), resveratrol was diluted to 0.1M with DMSO, and then diluted with DMEM containing 2% serum to ( 1.56 μM, 3.13 μM, 6.25 μM, 12.5 μM, 25 μM, 50 μM, 100 μM, 200 μM), for later culture.

[0023] The Vero ce...

Embodiment 2

[0025] In order to clarify the effect of resveratrol on cytotoxicity, this study was detected by CCK-8 kit. The CCK-8 reagent used in this experiment was purchased from China Suo Lai Bao Company (product number: CK04).

[0026] Vero cells were plated in 96-well plates after 4-5 passages, with 100 μl of cell suspension per well. The culture plate was pre-cultured in the incubator for 24 hours until the cells grew to 80%, the resveratrol was diluted to 0.1M with DMSO, and then the resveratrol was diluted with DMEM containing 10% serum to (1.56 μM, 3.13 μM , 6.25 μM, 12.5 μM, 25 μM, 50 μM, 100 μM, 200 μM), DMEM containing 0.05% DMSO was prepared with DMEM containing 10% serum as a drug blank control, and three wells were selected with only basal medium and CCK-8 reagent without The blank group of cell suspension was used as blank control. Add 10 μl of the above substances to be tested at different concentrations to the culture plate, each group has 3 repetitions, incubate in th...

Embodiment 3

[0034] This study needs to further clarify at what stage of viral infection resveratrol can play a role in order to further determine the main mechanism by which resveratrol may play a role.

[0035] The addition of resveratrol is mainly divided into four stages:

[0036] 1. Pre-infection treatment: Dilute resveratrol to 50 μM with DMEM containing 10% serum, pretreat the cells for 2 hours, then discard the pretreatment solution, wash three times with DMEM without serum, wash with DMEM without serum Dilute the virus, add the virus at MOI-0.01 and incubate for 2 hours, then wash the virus away and wash three times with serum-free DMEM. Subsequently, the cells were cultured with DMEM containing 2% serum until the sample was collected for 48 hours;

[0037] 2. Treatment during infection: Dilute resveratrol to 50 μM with serum-free DMEM to make solution A, then dilute the virus with solution A to MOI-0.01, incubate the cells for 2 hours, discard the incubation solution, and use se...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of resveratrol and derivatives thereof in preparation of an anti-novel coronavirus drug; in the application, resveratrol is used as a human health product, can significantly inhibit in vitro replication of novel coronavirus virus, and has relatively low cytotoxicity. In consideration of the immunomodulatory function of resveratrol, resveratrol is recommended for clinical prevention or treatment of novel coronavirus pneumonia patients. Therefore, the invention also provides the anti-novel coronavirus drug.

Description

technical field [0001] The invention belongs to the technical field of antiviral drugs, in particular to an anti-new coronavirus drug and its application. Background technique [0002] The new coronavirus is also known as 2019-nCoV. Common signs of people infected with the new coronavirus include respiratory symptoms, fever, cough, shortness of breath, and dyspnea. In more severe cases, infection can lead to pneumonia, severe acute respiratory syndrome, kidney failure, and even death. At present, there is no specific treatment for the disease caused by the new coronavirus, and the production of antibodies and vaccines also requires a large number of clinical trials for verification. Therefore, in order to prevent the further spread of the epidemic and treat infected patients as soon as possible, it is urgent to screen anti-new coronavirus drugs. [0003] Resveratrol, a typical stilbene polyphenol compound, is an antitoxin produced by many plants when stimulated. It can be...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/05A61P31/14A61P11/00A61P29/00A61P11/14
CPCA61K31/05A61P31/14A61P11/00A61P29/00A61P11/14
Inventor 刘映霞杨明辉韦金丽杨扬黄婷赖锦志刘磊
Owner THE THIRD PEOPLES HOSPITAL OF SHENZHEN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products